ARIEL4: An international, randomised phase 3 study of rucaparib vs chemotherapy as treatment for BRCA1- or BRCA2-mutated, relapsed ovarian cancer
Lorusso, D., Nicoletta, C., Sandro, P., Roberto, S., Paolo, S., Claudio, Z., Amit, M.O., Ana, O., Tamar, S., Elizabeth, M.S., Igor, M.B., Tomasz, H., Jaroslav, K., Vladimir, M., Róbert, P., Luciana, S.V., Chris, T., Caro, U., Adam, D., Rebecca, S.K.
Published in Annals of oncology (01.10.2017)
Published in Annals of oncology (01.10.2017)
Get full text
Journal Article